Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cecilia Perret

Showing results (41-50 of 42) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 42 results.
Vaccines|October 28, 2023
Different Safety Pattern of an Inactivated SARS-CoV-2 Vaccine (CoronaVac<sup>®</sup>) According to Age Group in a Pediatric Population from 3 to 17 Years Old, in an Open-Label Study in ChileNicole Le Corre, Katia Abarca, Patricio Astudillo, et al.
Mbio|November 16, 2022
Inactivated Vaccine-Induced SARS-CoV-2 Variant-Specific Immunity in ChildrenJorge A Soto, Felipe Melo-González, Cristián Gutierrez-Vera, et al.
Pageof 5

Showing results (41-50 of 42) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 42 results.
Vaccines|October 28, 2023
Different Safety Pattern of an Inactivated SARS-CoV-2 Vaccine (CoronaVac<sup>®</sup>) According to Age Group in a Pediatric Population from 3 to 17 Years Old, in an Open-Label Study in ChileNicole Le Corre, Katia Abarca, Patricio Astudillo, et al.
Mbio|November 16, 2022
Inactivated Vaccine-Induced SARS-CoV-2 Variant-Specific Immunity in ChildrenJorge A Soto, Felipe Melo-González, Cristián Gutierrez-Vera, et al.
Pageof 5